World's Best Scientists 2026 revealed!
Michael Papamichail

Michael Papamichail

D-Index & Metrics

Immunology

D-Index
48
Citations
10157
World Ranking
4409
National Ranking
10

Michael Papamichail publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael Papamichail sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 175 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael Papamichail D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Papamichail sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 48 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael Papamichail is affiliated with St Savas Hospital in Greece and has contributed to research primarily in medicine, with a focus on oncology, genetics, and endocrinology, diabetes, and metabolism. Their work spans the fields of pancreatic and hepatic oncology research, cancer genomics and diagnostics, immunotherapy and immune responses, as well as genetic and phenotypic traits in livestock.

Their prominent research topics include:

  • Pancreatic and Hepatic Oncology Research
  • Monoclonal and Polyclonal Antibodies Research
  • Immunotherapy and Immune Responses
  • HER2/EGFR in Cancer Research
  • Renal cell carcinoma treatment
  • Cancer Genomics and Diagnostics
  • Genetic and phenotypic traits in livestock

Michael Papamichail has published in several academic venues, notably:

  • HPB (3 publications)
  • Breast Cancer Research and Treatment (1 publication)
  • Fishes (1 publication)

Frequent co-authors in their research network include David Bartlett, Ravi Marudanayagam, N. Chatzizacharias, Saad Rehman, and M. Alarabiyat.

Key published papers by Michael Papamichail include:

  • "Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence" (2020), published in Breast Cancer Research and Treatment
  • "Arterial resections in pancreatic cancer surgery: experience from a tertiary care specialised HPB unit" (2024), published in HPB
  • "Pancreatectomy with arterial resections for locally advanced pancreatic cancer" (2024), published in HPB
  • "Investigating the Impact of six6 Genetic Variation on Morphological Traits in Larvae and Juveniles of European Seabass (Dicentrarchus labrax Linnaeus)" (2025), published in Fishes
  • "Improving Postoperative Glycaemic Control in Distal Pancreatectomy: A Retrospective Audit and Guideline" (2025), published in HPB

Their recent work includes clinical and genetic research with multidisciplinary implications. The studies on pancreatic cancer and surgical oncology reveal involvement in advanced clinical procedures and postoperative care guidelines. Their investigations into the genetic variation in European seabass indicate a broader interest encompassing genetic and phenotypic research beyond human medicine.

Best Publications

  • Interactions between human mesenchymal stem cells and natural killer cells.

    Panagiota A. Sotiropoulou;Sonia A. Perez;Angelos D. Gritzapis;Constantin N. Baxevanis

  • Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells.

    Panagiota A. Sotiropoulou;Sonia A. Perez;Maria Salagianni;Constantin N. Baxevanis

  • Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium.

    Demosthenes G. Katritsis;Panagiota A. Sotiropoulou;Evangelia Karvouni;Ilias Karabinos

  • Immunoglobulins on the surface of human lymphocytes.

    M. Papamichail;J.C. Brown;E.J. Holborow

  • An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry.

    Nikolaos G. Papadopoulos;George V.Z. Dedoussis;Gregory Spanakos;Angelos D. Gritzapis

  • A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer

    Eleni G. Iliopoulou;Panteleimon Kountourakis;Michalis V. Karamouzis;Dimitrios Doufexis

  • Complement dependence of localisation of aggregated IgG in germinal centres.

    M. Papamichail;C. Gutierrez;P. Embling;P. Johnson

  • Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrow-derived mesenchymal stem cells.

    Olga Katsara;Louisa G. Mahaira;Eleni G. Iliopoulou;Ardiana Moustaki

  • Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor.

    Constantin N. Baxevanis;Ioannis F. Voutsas;Ourania E. Tsitsilonis;Angelos D. Gritzapis

  • Subpopulations of human peripheral blood lymphocytes distinguished by combined rosette formation and membrane immunofluorescence.

    M. Papamichail;E.J. Holborow;HazelI. Keith;H.L.F. Currey

  • Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy

    Constantin N. Baxevanis;Sonia A. Perez;Michael Papamichail

  • Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).

    Costas Phenekos;Andromachi Vryonidou;Angelos D. Gritzapis;Constantinos N. Baxevanis

  • Defining the critical hurdles in cancer immunotherapy

    Bernard A. Fox;Bernard A. Fox;Dolores J. Schendel;Lisa H. Butterfield;Steinar Aamdal

  • Natural killer lymphocytes: biology, development, and function.

    Michael Papamichail;Sonia A. Perez;Angelos D. Gritzapis;Constantin N. Baxevanis

  • Cancer immunotherapy

    Unknown

  • Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer

    Constantin N. Baxevanis;George J. Reclos;Angelos D. Gritzapis;George V. Z. Dedousis

  • A new era in anticancer peptide vaccines

    Sonia A. Perez;Eric von Hofe;Nikoletta L. Kallinteris;Angelos D. Gritzapis

  • Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer

    Constantin N. Baxevanis;George V. Z. Dedoussis;Nikolaos G. Papadopoulos;Ioannis Missitzis

  • Cell culture medium composition and translational adult bone marrow-derived stem cell research.

    Panagiota A. Sotiropoulou;Sonia A. Perez;Maria Salagianni;Constantin N. Baxevanis

  • CD4+CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients.

    Sonia A. Perez;Michael V. Karamouzis;Dimosthenes V. Skarlos;Alexandros Ardavanis

  • Abnormal cytokine serum levels correlate with impaired cellular immune responses after surgery.

    Constantin N. Baxevanis;Konstantinos Papilas;George V.Z. Dedoussis;Theodor Pavlis

  • Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells.

    Demosthenes G. Katritsis;Panagiota Sotiropoulou;Eleftherios Giazitzoglou;Evangelia Karvouni

  • Compromised anti-tumor responses in tumor necrosis factor-α knockout mice

    Constantin N. Baxevanis;Ioannis F. Voutsas;Ourania E. Tsitsilonis;Marinos L. Tsiatas

  • Immunogenic HER-2/neu peptides as tumor vaccines

    Constantin N. Baxevanis;Nectaria N. Sotiriadou;Angelos D. Gritzapis;Panagiota A. Sotiropoulou

Frequent Co-Authors

Constantin N. Baxevanis
Constantin N. Baxevanis St Savas Hospital
Elizabeth A. Mittendorf
Elizabeth A. Mittendorf Brigham and Women's Hospital
George Dedoussis
George Dedoussis Harokopio University
Wolfgang Voelter
Wolfgang Voelter University of Tübingen
John D. Lambris
John D. Lambris University of Pennsylvania
Graham Pawelec
Graham Pawelec University of Tübingen
Nikolaos G. Papadopoulos
Nikolaos G. Papadopoulos National and Kapodistrian University of Athens
Xuetao Cao
Xuetao Cao Chinese Academy of Medical Sciences & Peking Union Medical College
James P. Allison
James P. Allison The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare degrees offer diverse career opportunities, especially in nursing and advanced practice roles. Exploring the cheapest pmhnp programs can be a practical option for students seeking affordable pathways to becoming Psychiatric Mental Health Nurse Practitioners, a specialization closely linked to immunological health in mental wellness contexts.

Understanding potential earnings is crucial when choosing a career path. The dnp salary by state provides valuable insights into compensation differences for Doctor of Nursing Practice graduates, helping candidates make informed decisions about where to pursue work after graduation.

Nurses aiming to specialize further may consider transition programs. Detailed guidance is available on how to move from family care roles to specialized acute care through the fnp to acute care np bridge program, which supports career advancement in critical care settings, often connected to immunologic disorders and patient management.

For accelerated career entry, many students turn to reputable accelerated nurse practitioner programs. These programs fast-track the path to becoming an NP, allowing professionals to enter immunology-related healthcare fields more quickly while gaining essential clinical skills.

Best Scientists Citing Michael Papamichail

Trending Scientists

Recently Published Articles